Back
Stepan Co. 10K Form
Sell
47
SCL
Stepan Co.
Last Price:
$45.02
Seasonality Move:
2.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | SCL/Stepan Co. Quarterly |
| 2023-11-02 | 10Q | SCL/Stepan Co. Quarterly |
| 2023-08-03 | 10Q | SCL/Stepan Co. Quarterly |
| 2023-05-04 | 10Q | SCL/Stepan Co. Quarterly |
| 2022-11-03 | 10Q | SCL/Stepan Co. Quarterly |
| 2022-08-04 | 10Q | SCL/Stepan Co. Quarterly |
Receive SCL News And Ratings
See the #1 stock for the next 7 days that we like better than SCL
SCL Financial Statistics
Sales & Book Value
| Annual Sales: | $2.2B |
|---|---|
| Cash Flow: | $40.2M |
| Price / Cash Flow: | 32.12 |
| Annual Sales: | $55.12 |
| Price / Book: | 0.82 |
Profitability
| EPS (TTM): | 1.97650 |
|---|---|
| Net Income (TTM): | $45.2M |
| Gross Margin: | $272.2M |
| Return on Equity: | 3.72% |
| Return on Assets: | 1.89% |
Stepan Co. Earnings Forecast
Key Stepan Co. Financial Ratios
-
The Gross Profit Margin over the past 41 years for SCL is 12.48%.
-
The Selling, General & Administrative Expenses for SCL have been equal to 6.60% of Gross Profit Margin.
-
The Research & Development expenses have been 2.55% of Revenue.
-
The Interest Expense is 38.64% of Operating Income.
-
The Net Earning history of SCL is 2.31% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 25 years.
Stepan Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | SCL |
| CUSIP: | 858586 |
| Website: | stepan.com |
Debt
| Debt-to-Equity Ratio: | 0.58 |
|---|---|
| Current Ratio: | 1.3 |
| Quick Ratio: | 0.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.49 |
|---|---|
| Forward P/E Ratio: | 12.81 |
SCL Technical Analysis vs Fundamental Analysis
Sell
47
Stepan Co. (SCL)
is a Sell
Is Stepan Co. a Buy or a Sell?
-
Stepan Co. stock is rated a SellThe current Stepan Co. [SCL] share price is $45.01. The Score for SCL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.